1. Home
  2. OVID vs MCI Comparison

OVID vs MCI Comparison

Compare OVID & MCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OVID

Ovid Therapeutics Inc.

N/A

Current Price

$2.39

Market Cap

421.8M

Sector

Health Care

ML Signal

N/A

Logo Barings Corporate Investors

MCI

Barings Corporate Investors

N/A

Current Price

$17.37

Market Cap

378.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
OVID
MCI
Founded
2014
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
421.8M
378.5M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
OVID
MCI
Price
$2.39
$17.37
Analyst Decision
Strong Buy
Analyst Count
13
0
Target Price
★ $6.40
N/A
AVG Volume (30 Days)
★ 1.8M
28.7K
Earning Date
11-16-2026
01-01-0001
Dividend Yield
N/A
★ 8.46%
EPS Growth
★ 3.90
N/A
EPS
N/A
★ 1.82
Revenue
★ $7,252,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$9.81
Revenue Growth
★ 1181.27
N/A
52 Week Low
$1.18
$16.21
52 Week High
$3.11
$21.50

Technical Indicators

Market Signals
Indicator
OVID
MCI
Relative Strength Index (RSI) 50.51 38.54
Support Level $2.09 $16.49
Resistance Level $2.44 $18.08
Average True Range (ATR) 0.20 0.37
MACD 0.04 -0.03
Stochastic Oscillator 53.28 8.88

Price Performance

Historical Comparison
OVID
MCI

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About MCI Barings Corporate Investors

Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations, including bank loans and mezzanine debt instruments. The Trust typically purchases these investments, which are not publicly tradable, directly from their issuers in private placement transactions, and the investments are typically made to small or middle market companies.

Share on Social Networks: